Cargando…
NE‐58025: A bisphosphonate with a low hydroxyapatite binding affinity
Autor principal: | Pazianas, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328800/ https://www.ncbi.nlm.nih.gov/pubmed/34368606 http://dx.doi.org/10.1002/jbm4.10502 |
Ejemplares similares
-
Reply to: A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation
por: Coffman, Abigail A, et al.
Publicado: (2021) -
Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker: reply to Yarom and Elad
por: Pazianas, M., et al.
Publicado: (2008) -
A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation
por: Coffman, Abigail A, et al.
Publicado: (2021) -
Eliminating the need for fasting with oral administration of bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2013) -
Atrial fibrillation and the use of oral bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2011)